Blood analysis data.
The hemogram of controls and patients before and after treatment with FVIII is shown in Table 2 (suppl). There were no differences between controls and patients in any variable, although leucocytes and lymphocytes number was significantly lower after administering FVIII to HA patients. Similarly, mean platelet volume was also significantly decreased in FVIII-treated HA patients. The data obtained in the special coagulation study are shown in Table 3 (suppl). As expected, we observed statistically significant differences in the amount of FVIII before and after FVIII infusion, as well as with control subjects (p <0.001). In the rest of the parameters, VWF:Ag and VWF:Rco, no significant differences were observed between groups.